SCHEMBL7877995

SCHEMBL7877995

CNC(N)=NC(=O)c1cc2ccc(OCc3ccc(CN)cc3)cc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 3/20 0.47
PDGFRB P09619 1/20 0.42
PDGFRA P16234 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
SRD5A2 P31213 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CFD P00746 1/20 0.41
MAOB P27338 7/20 0.39
MAOA P21397 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ACHE P22303 1/20 0.38
FGFR1 P11362 1/20 0.38
FGFR2 P21802 1/20 0.38
FGFR3 P22607 1/20 0.38
NPC1 O15118 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7878034 0.93 FLT3 (0.47) FLT3PDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL7877734 0.90 FLT3 (0.46) FLT3PDGFRBPDGFRAKDM4EALDH1A1
Hydrochloric Acid SCHEMBL7877491 0.90 FLT3 (0.57) FLT3PDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL7881191 0.90 KMT2A (0.39) FLT3PDGFRBPDGFRAMEN1KMT2A
SCHEMBL7873709 0.88 HRH3 (0.47) FLT3PDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL7884907 0.86 FLT3 (0.43) FLT3PDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL7880084 0.85 FLT3 (0.39) FLT3PDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL7881585 0.85 FLT3 (0.39) FLT3PDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL7879728 0.85 FLT3 (0.43) FLT3PDGFRBPDGFRAMEN1KMT2A
SCHEMBL7877501 0.85 KMT2A (0.41) FLT3PDGFRBPDGFRAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed